FDA Clinical Investigator Training Course (CITC) 2024 - Day Two - Session Two
Рет қаралды 462
Күн бұрынThis annual training course provided participants with the essential knowledge and skills to conduct clinical trials effectively, ethically, and in accordance with regulatory standards. Session two of day two covered topics such as new trends in trial designs, Digital Health Technologies (DHT), decentralized trials, mRNA vaccines, and innovative therapeutics in gene therapy.
01:04 - Innovative Approaches to Clinical Trials
31:15 - Informed Consent: More than just a document
01:02:45 - Q&A Discussion Panel 1
01:21:45 - mRNA Vaccines
01:52:01 - Innovative Therapeutics: Gene Therapy
02:11:44 - Q&A Discussion Panel 2
Speakers | Panelists
Leonard Sacks, MBBCh
Associate Director for Clinical Methodologies
Office of Medical Policy (OMP)
CDER | FDA
Ann Meeker-O'Connell, MS
Director
Office of Clinical Policy (OCP)
Office of the Chief Medical Officer (OCMO)
Office of the Commissioner (OC) | FDA
(Moderator for Q&A session 2)
Mili Duggal
Health Science Policy Analyst
OMP | CDER | FDA
Karin Bok, MS, PhD
Deputy Director
Office of Vaccines Research & Review (OVRR)
Center for Biologics Evaluation and Research (CBER) | FDA
Nicole Verdun, MD
Super Office Director
Office of Therapeutic Products (OTP)
CBER | FDA
(Moderator for Q&A session 3)
Leonard Sacks, MBBCh
Associate Director for Clinical Methodologies
Office of Medical Policy (OMP)
CDER | FDA
Learn more at: www.fda.gov/dr...
-----------------------
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming Training - www.fda.gov/cd...
SBIA Listserv - public.govdeli...
SBIA 2024 Playlist - • 2024 CDER Small Busine...
SBIA LinkedIn - / cder-small-business-an...
SBIA Training Resources - www.fda.gov/cd...
Twitter - / fda_drug_info
Email - CDERSBIA@fda.hhs.gov
Phone - (301) 796-6707 I (866) 405-5367
U.S. Food and Drug Administration
Рет қаралды 331
U.S. Food and Drug Administration
Рет қаралды 775
U.S. Food and Drug Administration
Рет қаралды 520
U.S. Food and Drug Administration
Рет қаралды 685
U.S. Food and Drug Administration
Рет қаралды 1,3 М.
U.S. Food and Drug Administration
Рет қаралды 1,5 М.
FDA D.I.S.C.O. Burst Edition: FDA approval of Ryoncil (remestemcel-L-rknd) for steroid-refractory...
U.S. Food and Drug Administration
Рет қаралды 265
U.S. Food and Drug Administration
Рет қаралды 514
U.S. Food and Drug Administration
Рет қаралды 1,2 М.
U.S. Food and Drug Administration
Рет қаралды 507
U.S. Food and Drug Administration
Рет қаралды 167